MENLO
PARK, Calif., Feb. 27,
2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading
developer of high-quality, highly accurate sequencing solutions,
announced today that it will be participating in Cowen's 43rd
Annual Health Care Conference in Boston,
Massachusetts.
PacBio management is scheduled to participate in a fireside chat
on Tuesday, March 7th at 12:50 PM ET. Interested parties may access a live
and archived webcast of the event at the company's investors page
at investor.pacificbiosciences.com.
About PacBio
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier
life science technology company that is designing, developing and
manufacturing advanced sequencing solutions to help scientists and
clinical researchers resolve genetically complex problems. Our
products and technology under development stem from two highly
differentiated core technologies focused on accuracy, quality and
completeness which include our existing HiFi long read sequencing
and our emerging SBBâ„¢ short read sequencing technologies. Our
products address solutions across a broad set of research
applications including human germline sequencing, plant and animal
sciences, infectious disease and microbiology, oncology, and other
emerging applications. For more information, please visit
www.pacb.com and follow @PacBio.
Contacts
Investors:
Todd
Friedman
650.521.8450
ir@pacb.com
Media:
Lizelda Lopez
pr@pacb.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pacbio-to-present-at-cowens-43rd-annual-health-care-conference-301756079.html
SOURCE Pacific Biosciences of California, Inc.